Comparison of Efficacy and Dermatology Life Quality Index of Pharmacological Monotherapy and Combined Therapy in Patients with Chronic Idiopathic Urticaria

CHEN Man-xuan,LIU Ling-ling
DOI: https://doi.org/10.3969/j.issn.1673-8705.2011.03.012
2011-01-01
Abstract:Objective To compare the clinical efficacy and the improvement of quality of life between the two treatment groups by using non-sedative H1-antihistamine agents as monotherapy and combined therapy in chronic idiopathic urticaria(CIU) patients.Methods 161 CIU patients with comprehensive clinical data diagnosed in outpatient were collected.Clinical data of patients were retrospectively analyzed.The 161 patients were divided in two treatment groups,monotherapy group,only using one kind of non-sedative H1-antihistamine agent(QD) and combined therapy group,combined using one kind of non-sedative H1-antihistamine agent(QD) with other medication.The duration of therapy was four weeks.Patients were evaluated before treatment,week two and week four.Urticaria activity score(UAS) and symptom score reducing index(SSRI) were used to assess patients' symptoms and signs,as well as the overall efficacy of the treatment.The dermatology life quality index(DLQI) was used to assess the improvement of the patients' quality of life.Results 161 CIU patients were enrolled in this study,107 cases in monotherapy group and 54 cases in combined therapy group respectively.After 4 weeks treatment,the effective rate of combined therapy and monotherapy group was 72.3% and 72.9% respectively,there is no significant difference between the two treatment groups statistically(χ2=0.008,P=0.928).The cure rate of combined therapy group(51.9%) was higher than that of monotherapy group(40.2%),there is also no significant difference between the two treatment groups statistically(χ2=1.98,P=0.159).At the end of 4 weeks treatment,the assessment of UAS shown that there was no significant difference statistically between the two treatment groups(P0.05).The DLQI scores of the both groups decreased at the end of 4 weeks treatment,but the combined therapy group shown further improvement than monotherapy group in terms of quality of life,there is no significant difference statistically between the two treatment groups(P=0.052).Conclusions The overrall efficacy of the non-sedative H1-antihistamine agent monotherapy and combined therapy in the treatment of CIU is similar,but the cure rate of combined therapy is slightly higher than monotherapy,furthermore,it seems to achieve the better persistence of symptoms controlling and relieving.And the quality of life of patients will CIU in the combined therapy group achieves further improvement.
What problem does this paper attempt to address?